Search

Taiwo Oladapo

Examiner (ID: 13527, Phone: (571)270-3723 , Office: P/1771 )

Most Active Art Unit
1771
Art Unit(s)
1797, 1771
Total Applications
1276
Issued Applications
617
Pending Applications
137
Abandoned Applications
548

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11395184 [patent_doc_number] => 20170015719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-19 [patent_title] => 'CHIMERIC POLYPEPTIDE COMPRISING THE FRAGMENT B OF SHIGA TOXIN AND PEPTIDES OF THERAPEUTIC INTEREST' [patent_app_type] => utility [patent_app_number] => 13/952068 [patent_app_country] => US [patent_app_date] => 2013-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6403 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13952068 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/952068
CHIMERIC POLYPEPTIDE COMPRISING THE FRAGMENT B OF SHIGA TOXIN AND PEPTIDES OF THERAPEUTIC INTEREST Jul 25, 2013 Abandoned
Array ( [id] => 10945841 [patent_doc_number] => 20140348862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'Prame derived peptides and immunogenic compositions comprising these' [patent_app_type] => utility [patent_app_number] => 13/945335 [patent_app_country] => US [patent_app_date] => 2013-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16155 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13945335 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/945335
Prame derived peptides and immunogenic compositions comprising these Jul 17, 2013 Issued
Array ( [id] => 9160983 [patent_doc_number] => 20130309260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'HUMAN CYTOTOXIC T-LYMPHOCYTE EPITOPE AND ITS AGONIST EPITOPE FROM THE NON-VARIABLE NUMBER OF TANDEM REPEAT SEQUENCE OF MUC-1' [patent_app_type] => utility [patent_app_number] => 13/941705 [patent_app_country] => US [patent_app_date] => 2013-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 38423 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941705 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/941705
Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 Jul 14, 2013 Issued
13/701299 XYXIN FRAGMENT BIOMARKER FOR DIAGNOSIS OF COLON CANCER Jul 11, 2013 Abandoned
Array ( [id] => 9122339 [patent_doc_number] => 20130289261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'THERAPEUTIC AND DIAGNOSTIC CLONED MHC-UNRESTRICTED RECEPTOR SPECIFIC FOR THE MUC1 TUMOR ASSOCIATED ANTIGEN' [patent_app_type] => utility [patent_app_number] => 13/939988 [patent_app_country] => US [patent_app_date] => 2013-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17090 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13939988 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/939988
Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen Jul 10, 2013 Issued
Array ( [id] => 9792678 [patent_doc_number] => 20150004621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'BIOLOGICAL MARKER FOR EARLY CANCER DETECTION AND METHODS FOR CANCER DETECTION (BF819)' [patent_app_type] => utility [patent_app_number] => 13/931432 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26463 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13931432 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/931432
BIOLOGICAL MARKER FOR EARLY CANCER DETECTION AND METHODS FOR CANCER DETECTION (BF819) Jun 27, 2013 Abandoned
Array ( [id] => 9081430 [patent_doc_number] => 20130266960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'Methods And Kits For Differential Staining Of Abnormal Urinary System Cells' [patent_app_type] => utility [patent_app_number] => 13/900055 [patent_app_country] => US [patent_app_date] => 2013-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10843 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900055 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/900055
Methods And Kits For Differential Staining Of Abnormal Urinary System Cells May 21, 2013 Abandoned
Array ( [id] => 10283411 [patent_doc_number] => 20150168409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'METHOD FOR DETERMINING IF A SUBJECT HAS AN INCREASED LIKELIHOOD OF HIGH GRADE DYSPLASIA OR ESOPHAGEAL ADENOCARCINOMA' [patent_app_type] => utility [patent_app_number] => 14/402034 [patent_app_country] => US [patent_app_date] => 2013-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20847 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402034 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/402034
METHOD FOR DETERMINING IF A SUBJECT HAS AN INCREASED LIKELIHOOD OF HIGH GRADE DYSPLASIA OR ESOPHAGEAL ADENOCARCINOMA May 16, 2013 Abandoned
Array ( [id] => 9546726 [patent_doc_number] => 20140171374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-19 [patent_title] => 'USE OF A TRUNCATED EIF-5A1 POLYNUCLEOTIDE TO INDUCE APOPTOSIS IN CANCER CELLS' [patent_app_type] => utility [patent_app_number] => 13/895756 [patent_app_country] => US [patent_app_date] => 2013-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 25914 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13895756 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/895756
USE OF A TRUNCATED EIF-5A1 POLYNUCLEOTIDE TO INDUCE APOPTOSIS IN CANCER CELLS May 15, 2013 Abandoned
Array ( [id] => 9269114 [patent_doc_number] => 20140024030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'PRESELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT WITH OXYGEN SENSITIVE AGENTS BASED IN HYPOXIC STATUS' [patent_app_type] => utility [patent_app_number] => 13/895709 [patent_app_country] => US [patent_app_date] => 2013-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 61715 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13895709 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/895709
PRESELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT WITH OXYGEN SENSITIVE AGENTS BASED IN HYPOXIC STATUS May 15, 2013 Abandoned
13/895543 METHODS FOR TREATING CANCER WITH NOTCH2/3 ANTIBODIES May 15, 2013 Abandoned
Array ( [id] => 9134866 [patent_doc_number] => 20130295581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'Methods and Compositions for the Treatment and Diagnosis of Breast Cancer' [patent_app_type] => utility [patent_app_number] => 13/888254 [patent_app_country] => US [patent_app_date] => 2013-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19889 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13888254 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/888254
Methods and Compositions for the Treatment and Diagnosis of Breast Cancer May 5, 2013 Abandoned
Array ( [id] => 9033858 [patent_doc_number] => 20130236497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'TREATING NEOPLASMS WITH NEUROTOXIN' [patent_app_type] => utility [patent_app_number] => 13/875542 [patent_app_country] => US [patent_app_date] => 2013-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14577 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875542 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/875542
TREATING NEOPLASMS WITH NEUROTOXIN May 1, 2013 Abandoned
Array ( [id] => 10248331 [patent_doc_number] => 20150133327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'METHOD FOR DETECTING OR MONITORING PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 14/395459 [patent_app_country] => US [patent_app_date] => 2013-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10002 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395459 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/395459
METHOD FOR DETECTING OR MONITORING PROSTATE CANCER Apr 18, 2013 Abandoned
Array ( [id] => 9900993 [patent_doc_number] => 20150056193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'EGFR AND ROS1 KINASE IN CANCER' [patent_app_type] => utility [patent_app_number] => 14/394793 [patent_app_country] => US [patent_app_date] => 2013-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 34053 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14394793 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/394793
EGFR AND ROS1 KINASE IN CANCER Apr 17, 2013 Abandoned
Array ( [id] => 9175097 [patent_doc_number] => 20130317082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/857775 [patent_app_country] => US [patent_app_date] => 2013-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16535 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13857775 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/857775
METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER Apr 4, 2013 Abandoned
Array ( [id] => 10219823 [patent_doc_number] => 20150104816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'MARKER FOR DETECTING PANCREATIC CANCER' [patent_app_type] => utility [patent_app_number] => 14/401660 [patent_app_country] => US [patent_app_date] => 2013-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5558 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401660 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/401660
MARKER FOR DETECTING PANCREATIC CANCER Mar 31, 2013 Abandoned
Array ( [id] => 9910373 [patent_doc_number] => 20150065575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-05 [patent_title] => 'S100A8/A9 as a Diagnostic Marker and a Therapeutic Target' [patent_app_type] => utility [patent_app_number] => 14/389237 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 17611 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389237 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/389237
S100A8/A9 as a Diagnostic Marker and a Therapeutic Target Mar 14, 2013 Abandoned
Array ( [id] => 8951148 [patent_doc_number] => 20130196929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE (SPARC) AS CHEMOTHERAPEUTIC SENSITIZERS' [patent_app_type] => utility [patent_app_number] => 13/827567 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13737 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13827567 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/827567
SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE (SPARC) AS CHEMOTHERAPEUTIC SENSITIZERS Mar 13, 2013 Abandoned
Array ( [id] => 8950574 [patent_doc_number] => 20130196355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'Method and a kit to quantify and qualify exosomes for diagnosis of prostate cancer and prostate hyperplasia' [patent_app_type] => utility [patent_app_number] => 13/803561 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3710 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13803561 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/803561
Method and a kit to quantify and qualify exosomes for diagnosis of prostate cancer and prostate hyperplasia Mar 13, 2013 Abandoned
Menu